INSUBCONTINENT EXCLUSIVE:
Pfizer and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar
steps in the United States and Britain, the companies said on Tuesday
This article first appeared/also appeared in Mirror
